ClinicalTrials.govpublic full text
To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
her2-ve metastatic breast cancer, germline brca1/2 mutations, somatic brca1/2 mutations, brca1, brca2, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 916019
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.